6.2 Midline Catheters
Key Takeaways
- A midline catheter is a peripheral venous access device whose tip terminates in a peripheral vein at or near the axilla—not in the superior vena cava—so it is not a central line.
- Midlines support intermediate dwell (typically days to weeks) for selected peripheral-compatible therapies when short PIVs are insufficient or repeated sticks threaten vessel health.
- Do not use midlines for continuous vesicants, therapies with extreme osmolarity/pH that require central hemodilution, or TPN/PN regimens that standards assign to central access.
- Contrast midlines with PICCs: both may insert in the upper arm, but PICC tips are central (lower SVC/cavoatrial junction) while midline tips remain peripheral near the axilla.
- Midline care still requires aseptic insertion/maintenance, securement, site assessment, and complication surveillance (phlebitis, thrombosis, infiltration, occlusion, infection).
Midline catheters: intermediate peripheral access
Midline catheters are one of the most frequently misclassified devices on infusion exams. If you remember only one sentence, remember this: a midline tip is peripheral (at/near the axilla), not central (not in the SVC).
Quick Answer: A midline is inserted peripherally (often upper arm basilic/cephalic/brachial territory, frequently ultrasound-guided) with the catheter tip terminating in a peripheral vein at or near the axilla. It is not a CVAD. Dwell is often days to weeks for peripheral-compatible therapies. It is inappropriate for continuous vesicants, many extreme osmolarity/pH infusions that need central dilution, and TPN typically requiring central access. A PICC may look similar at the insertion site but ends in the lower SVC/cavoatrial junction.
Definition and tip location
| Attribute | Midline catheter |
|---|---|
| Device class | Peripheral venous access device |
| Typical insertion | Upper-arm peripheral vein (basilic common); ultrasound frequently used |
| Tip location | Peripheral vein at or near the axilla (not SVC) |
| Central line? | No |
| Typical dwell concept | Intermediate — days to weeks (product/policy specific; remove when no longer indicated or if complications) |
| Therapy fit | Peripheral-compatible fluids/meds for intermediate duration |
Why tip location matters: Hemodilution and blood flow increase dramatically as blood approaches and enters the central venous system. Therapies that depend on rapid dilution of vesicants or highly concentrated/osmolar solutions require a central tip. A midline does not provide that central hemodilution profile even though the catheter is longer than a short PIV and may feel “more serious” to patients and staff.
Midline versus PICC (must-know contrast)
Both devices are often placed in the upper arm with ultrasound and modified Seldinger or similar techniques. Superficial similarity causes dangerous shortcuts in thinking.
| Feature | Midline | PICC |
|---|---|---|
| Insertion region | Upper arm peripheral vein | Upper arm peripheral vein (often) |
| Tip destination | Peripheral — axilla region | Central — lower SVC near cavoatrial junction |
| Device class | Peripheral | CVAD |
| Continuous vesicants | No (not appropriate) | May be appropriate when tip confirmed central and therapy indicated |
| Typical PN/TPN | Not when central access is required | Often used when central PN indicated |
| CLABSI surveillance framing | Peripheral device (still infection risk) | CVAD / CLABSI definitions apply when criteria met |
| Confirmation of central tip | Not a central tip | Imaging/ECG tip confirmation per protocol |
Exam trap phrasing to reject: “Midlines are a type of central line because they are long.” False. Length and arm insertion do not equal central classification—tip location does.
Indications: when midlines help
Consider a midline when all of the following lean favorable:
- Therapy is peripheral-compatible (osmolarity, pH, vesicant/irritant profile acceptable for peripheral veins per standards/drug references/policy).
- Duration is intermediate—longer than practical repeated short-PIV restarts, but not clearly mandating a long-term CVAD pathway.
- Vessel health is threatened by multiple failed short PIVs or anticipated frequent access.
- Patient factors support upper-arm peripheral access (no absolute laterality restriction, adequate vein size on ultrasound, infection-free insertion site).
- Care setting can maintain midline dressings, flushes, and assessment (hospital, skilled nursing, or home infusion with trained caregivers as applicable).
Examples of therapy patterns that may fit (always verify drug-specific rules):
- Multi-day to multi-week intermittent antibiotics that are peripheral-appropriate
- Intermediate hydration or non-vesicant infusions when short PIVs keep failing
- Patients needing reliable access for several days without central therapy requirements
Contraindications and inappropriate uses (high-yield “do not” list)
Do not select a midline as a workaround for therapies that require central access:
| Inappropriate use | Why |
|---|---|
| Continuous vesicant infusion | Extravasation risk with inadequate central hemodilution; vesicant injury can be severe |
| Extreme osmolarity / extreme pH therapies designated for central veins | Chemical endothelial injury, phlebitis, thrombosis |
| TPN / PN formulations requiring central administration | Hyperosmolar nutrient admixtures need central blood flow |
| Using midline solely to “avoid a PICC” when central tip is required | Wrong device class for the chemistry |
| Insertion through infected skin or into a compromised limb without indication | Infection and vessel-preservation failures |
Irritants vs vesicants: Irritants cause inflammation and pain along the vein; vesicants can cause tissue necrosis if extravasated. Continuous vesicant administration is a central-access conversation, not a midline compromise. Some intermittent peripheral vesicant protocols exist only under tightly controlled policies—never assume a midline automatically authorizes continuous vesicant therapy.
Insertion and maintenance principles
Insertion
- Perform comprehensive vascular assessment and therapy review before skin prep.
- Prefer ultrasound for vein selection and real-time guidance when indicated.
- Use maximal sterile barrier and skin antisepsis consistent with organizational policy for midline insertion (midlines are longer dwell peripheral devices—asepsis intensity is taken seriously even though they are not CVADs).
- Measure and select length so the tip will reside at/near the axilla, not extend into the chest as an unconfirmed “almost PICC.”
- Confirm blood return and flush; secure with an appropriate engineered securement device; apply sterile dressing.
- Educate the patient: report arm swelling, pain, leakage, fever, dressing issues, and activity limits.
Maintenance
- Assess insertion site and limb every shift and with every use.
- Maintain dressing integrity; change on schedule and when damp, loose, or soiled.
- Flush with preservative-free 0.9% sodium chloride using push-pause technique as policy specifies; lock per protocol (note: midline lock solutions follow peripheral/device policy—do not invent central-only routines without indication).
- Minimize unnecessary hub entries; disinfect needleless connectors thoroughly.
- Remove when therapy is complete, the device fails, or complications mandate removal—do not keep a midline “for convenience” after the clinical need ends.
Complications associated with midlines
Midlines share peripheral complication patterns and add risks related to longer indwelling time and upper-arm deep veins:
| Complication | Clues | Implications |
|---|---|---|
| Chemical/mechanical phlebitis | Pain, erythema, warmth, palpable cord | Reassess therapy suitability; remove if indicated |
| Thrombosis | Unilateral arm edema, pain, dilated collaterals | Stop use; escalate evaluation; do not ignore progressive swelling |
| Infiltration / extravasation | Swelling, leakage, pain with infusion | Stop immediately; treat per infusate; higher harm if vesicant mistakenly infused |
| Occlusion | No blood return, resistance to flush | Do not force; follow occlusion algorithm; remove if unresolved |
| Infection (local or bloodstream) | Site purulence, fever, malaise | Culture/remove per protocol; midlines are not “infection-proof” |
| Nerve injury | Paresthesias during insertion | Stop; reassess anatomy |
Deep vein location myth: Because some midline veins are deeper, early infiltration can be subtler. Rely on symptoms, pump pressure trends, and limb comparison—not on “it looked fine under a thick arm.”
Clinical scenarios for exam thinking
Scenario A — Appropriate midline candidate: A patient needs 10–14 days of intermittent peripheral-compatible IV antibiotics, has exhausted forearm short PIVs, ultrasound shows a suitable upper-arm vein, and no continuous vesicant or PN is planned. A midline can reduce restarts and protect distal veins.
Scenario B — Wrong device: A patient will receive continuous vesicant chemotherapy and hyperosmolar PN. Staff suggest “just put in a midline so we don’t need a central line.” Incorrect. These therapies require appropriate central access with confirmed tip location.
Scenario C — Classification error: Documentation lists a midline under “central lines” for CLABSI bundle charting identical to a PICC without recognizing tip differences. Know that surveillance definitions and therapy rules hinge on device class and tip, not on the fact that both were inserted in the upper arm.
Comparison to short and long PIVs
| Device | Tip | Dwell concept | Role |
|---|---|---|---|
| Short PIV | Peripheral (near insertion) | Short; clinically indicated removal | First-line brief access |
| Long peripheral | Peripheral | Intermediate short-to-mid | Difficult access / deeper peripheral veins |
| Midline | Peripheral near axilla | Days to weeks | Intermediate peripheral-compatible therapy |
| PICC | Central (SVC) | Days to months (indication-based) | Central therapies / longer complex access |
High-yield exam traps
- Calling a midline a central line because it is long or upper-arm placed
- Approving continuous vesicant infusion via midline
- Using midline for TPN that requires central administration
- Assuming midline eliminates thrombosis and infection risk
- Confusing midline tip (axilla) with PICC tip (SVC/cavoatrial junction)
- Keeping a midline after therapy ends “in case we need access later” without indication
Where does a properly positioned midline catheter tip terminate?
Which therapy is generally inappropriate through a midline catheter?
Which statement correctly contrasts a midline with a PICC?
A nurse documents a newly inserted midline as a central line because the catheter is longer than a short PIV. What is the correct evaluation of that documentation?